Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
J Nucl Med ; 55(1): 43-9, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24337606

ABSTRACT

UNLABELLED: Targeting cancer cells with vitamin B12 (cobalamin) is hampered by unwanted physiologic tissue uptake mediated by transcobalamin. Adhering to good manufacturing practice, we have developed a new (99m)Tc-cobalamin derivative ((99m)Tc(CO)3-[(4-amido-butyl)-pyridin-2-yl-methyl-amino-acetato] cobalamin, (99m)Tc-PAMA-cobalamin). The derivative shows no binding to transcobalamin but is recognized by haptocorrin, a protein present in the circulation and notably expressed in many tumor cells. In this prospective study, we investigated cancer-specific uptake of (99m)Tc-PAMA-cobalamin in 10 patients with various metastatic tumors. METHODS: Ten patients with biopsy-proven metastatic cancer were included. Dynamic imaging was started immediately after injection of 300-500 MBq of (99m)Tc-PAMA-cobalamin, and whole-body scintigrams were obtained at 10, 30, 60, 120, and 240 min and after 24 h. The relative tumor activity using SPECT/CT over the tumor region after 4 h was measured in comparison to disease-free lung parenchyma. Patients 3-10 received between 20 and 1,000 µg of cobalamin intravenously before injection of (99m)Tc-PAMA-cobalamin. The study population comprised 4 patients with adenocarcinomas of the lung, 3 with squamous cell carcinomas of the hypopharyngeal region, 1 with prostate adenocarcinoma, 1 with breast, and 1 with colon adenocarcinoma. RESULTS: The median age of the study group was 61 ± 11 y. Six of 10 patients showed positive tumor uptake on (99m)Tc-PAMA-cobalamin whole-body scintigraphy. The scan was positive in 1 patient with colon adenocarcinoma, in 3 of 4 lung adenocarcinomas, in 1 of 3 hypopharyngeal squamous cell carcinomas, and in 1 breast adenocarcinoma. Renal uptake was between 1% and 3% for the left kidney. Predosing with cobalamin increased the tumor uptake and improved blood-pool clearance. The best image quality was achieved with a predose of 20-100 ug of cold cobalamin. The mean patient dose was 2.7 ± 0.9 mSv/patient. CONCLUSION: To our knowledge, we report for the first time on (99m)Tc-PAMA-cobalamin imaging in patients with metastatic cancer disease and show that tumor targeting is feasible.


Subject(s)
Neoplasms/diagnostic imaging , Organotechnetium Compounds/pharmacology , Radiopharmaceuticals/pharmacology , Technetium/pharmacology , Vitamin B 12/analogs & derivatives , Vitamin B 12/chemistry , Aged , Aged, 80 and over , Biopsy , Female , Humans , Male , Middle Aged , Multimodal Imaging , Neoplasm Metastasis , Prospective Studies , Radionuclide Imaging , Sensitivity and Specificity , Time Factors , Tissue Distribution , Tomography, Emission-Computed, Single-Photon , Tomography, X-Ray Computed , Vitamin B 12/pharmacology , Whole Body Imaging
2.
Eur Heart J Cardiovasc Imaging ; 14(10): 969-77, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23428650

ABSTRACT

OBJECTIVE: The assessment of coronary stents with present-generation 64-detector row computed tomography (HDCT) scanners is limited by image noise and blooming artefacts. We evaluated the performance of adaptive statistical iterative reconstruction (ASIR) for noise reduction in coronary stent imaging with HDCT. METHODS AND RESULTS: In 50 stents of 28 patients (mean age 64 ± 10 years) undergoing coronary CT angiography (CCTA) on an HDCT scanner the mean in-stent luminal diameter, stent length, image quality, in-stent contrast attenuation, and image noise were assessed. Studies were reconstructed using filtered back projection (FBP) and ASIR-FBP composites. ASIR resulted in reduced image noise vs. FBP (P < 0.0001). Two readers graded the CCTA stent image quality on a 4-point Likert scale and determined the proportion of interpretable stent segments. The best image quality for all clinical images was obtained with 40 and 60% ASIR with significantly larger luminal area visualization compared with FBP (+42.1 ± 5.4% with 100% ASIR vs. FBP alone; P < 0.0001) while the stent length was decreased (-4.7 ± 0.9%,


Subject(s)
Angioplasty, Balloon, Coronary/instrumentation , Coronary Stenosis/diagnostic imaging , Multidetector Computed Tomography/methods , Radiographic Image Interpretation, Computer-Assisted , Stents , Aged , Angioplasty, Balloon, Coronary/methods , Cohort Studies , Coronary Angiography/methods , Coronary Stenosis/therapy , Female , Humans , Image Processing, Computer-Assisted , Male , Middle Aged , Observer Variation , Quality Control , Radiation Dosage , Reproducibility of Results , Risk Assessment , Sensitivity and Specificity
3.
Int J Cardiol ; 167(6): 2932-7, 2013 Sep 10.
Article in English | MEDLINE | ID: mdl-22959869

ABSTRACT

OBJECTIVE: Assessment of coronary artery calcification is increasingly used for cardiovascular risk stratification. We evaluated the reliability of calcium-scoring results using a novel iterative reconstruction algorithm (ASIR) on a high-definition 64-slice CT scanner, as such data is lacking. METHODS AND RESULTS: In 50 consecutive patients Agatston scores, calcium mass and volume score were assessed. Comparisons were performed between groups using filtered back projection (FBP) and 20-100% ASIR algorithms. Calcium score was measured in the coronary arteries, signal and noise were measured in the aortic root and left ventricle. In comparison with FBP, use of 20%, 40%, 60%, 80%, and 100% ASIR resulted in reduced image noise between groups (7.7%, 18.8%, 27.9%, 39.86%, and 48.56%, respectively; p<0.001) without difference in signal (p=0.60). With ASIR algorithms Agatston coronary calcium scoring significantly decreased compared with FBP algorithms (837.3 ± 130.3; 802.2 ± 124.9, 771.5 ± 120.7; 744.7 ± 116.8, 724.5 ± 114.2, and 709.2 ± 112.3 for 0%, 20%, 40%, 60%, 80%, and 100% ASIR, respectively, p<0.001). Volumetric score decreased in a similar manner (p<0.001) while calcium mass remained unchanged. Mean effective radiation dose was 0.81 ± 0.08 mSv. CONCLUSION: ASIR results in image noise reduction. However, ASIR image reconstruction techniques for HDCT scans decrease Agatston coronary calcium scores. Thus, one needs to be aware of significant changes of the scoring results caused by different reconstruction methods.


Subject(s)
Calcium , Coronary Angiography/standards , Coronary Artery Disease/diagnostic imaging , Multidetector Computed Tomography/standards , Vascular Calcification/diagnostic imaging , Aged , Calcium/analysis , Coronary Artery Disease/epidemiology , Female , Humans , Male , Middle Aged , Vascular Calcification/epidemiology
4.
Circulation ; 126(4): 430-9, 2012 Jul 24.
Article in English | MEDLINE | ID: mdl-22767659

ABSTRACT

BACKGROUND: Evaluation of novel cellular therapies in large-animal models and patients is currently hampered by the lack of imaging approaches that allow for long-term monitoring of viable transplanted cells. In this study, sodium iodide symporter (NIS) transgene imaging was evaluated as an approach to follow in vivo survival, engraftment, and distribution of human-induced pluripotent stem cell (hiPSC) derivatives in a pig model of myocardial infarction. METHODS AND RESULTS: Transgenic hiPSC lines stably expressing a fluorescent reporter and NIS (NIS(pos)-hiPSCs) were established. Iodide uptake, efflux, and viability of NIS(pos)-hiPSCs were assessed in vitro. Ten (±2) days after induction of myocardial infarction by transient occlusion of the left anterior descending artery, catheter-based intramyocardial injection of NIS(pos)-hiPSCs guided by 3-dimensional NOGA mapping was performed. Dual-isotope single photon emission computed tomographic/computed tomographic imaging was applied with the use of (123)I to follow donor cell survival and distribution and with the use of (99m)TC-tetrofosmin for perfusion imaging. In vitro, iodide uptake in NIS(pos)-hiPSCs was increased 100-fold above that of nontransgenic controls. In vivo, viable NIS(pos)-hiPSCs could be visualized for up to 15 weeks. Immunohistochemistry demonstrated that hiPSC-derived endothelial cells contributed to vascularization. Up to 12 to 15 weeks after transplantation, no teratomas were detected. CONCLUSIONS: This study describes for the first time the feasibility of repeated long-term in vivo imaging of viability and tissue distribution of cellular grafts in large animals. Moreover, this is the first report demonstrating vascular differentiation and long-term engraftment of hiPSCs in a large-animal model of myocardial infarction. NIS(pos)-hiPSCs represent a valuable tool to monitor and improve current cellular treatment strategies in clinically relevant animal models.


Subject(s)
Graft Survival , Multimodal Imaging , Myocardial Infarction/metabolism , Myocardial Infarction/therapy , Pluripotent Stem Cells/metabolism , Pluripotent Stem Cells/transplantation , Positron-Emission Tomography , Stem Cell Transplantation , Symporters/metabolism , Tomography, X-Ray Computed , Animals , Cell Differentiation , Cell Survival , Disease Models, Animal , Feasibility Studies , Gene Expression , Heart/diagnostic imaging , Humans , In Vitro Techniques , Injections , Myocardial Infarction/pathology , Myocardium/metabolism , Myocardium/pathology , Stem Cell Transplantation/methods , Swine , Symporters/genetics , Transgenes , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...